Clinical manifestations of damage to the cardiovascular system and predictors of poor prognosis of Takayasu arteritis in Kyrgyz patients

QR Code

Clinical manifestations of damage to the cardiovascular system and predictors of poor prognosis of Takayasu arteritis in Kyrgyz patients

Damage to the cardiovascular system (CVS) in Takayasu arteritis (AT) is characterized by a wide range of clinical manifestations and an unfavorable prognosis of the disease. Objectives: determine the characteristics of clinical manifestations of damage to the CVS and predictors of unfavorable progno...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. M. Koilubaeva, A. M. Bolotbekova, M. T. Beishenkulov, O. N. Egorova, G. M. Tarasova, A. M. Lila, G. Suiunbay kyzy, A. T. Turatbekova, A. A. Okunova, M. A. Chukubaev, Z. E. Turdukulov, D. A. Usupbaeva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2023-10-01
Series:	Научно-практическая ревматология
Subjects:	takayasu arteritis aortic regurgitation arterial hypertension cardiovascular system
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3440
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical course, laboratory and instrumental markers of vascular inflammation in the Kyrgyz cohort of patients with Takayasu's arteritis
by: G. M. Koilubaeva, et al.
Published: (2022-10-01)

Modern approaches to the treatment of Takayasu arteritis
by: O. N. Egorova, et al.
Published: (2024-02-01)

Persistent effect of tocilizumab in refractory Takayasu’s arteritis (clinical observation)
by: G. M. Koilubaeva, et al.
Published: (2022-05-01)

Clinical manifestations, course variants and complications of Takayasu arteritis in Kyrgyz patients
by: G. M. Koilubaeva, et al.
Published: (2021-02-01)

Ankylosing spondylitis with concurrent Takayasu arteritis: a clinical case report
by: O. B. Nesmeyanova, et al.
Published: (2019-10-01)

The effect of late diagnosis on survival and risk of vascular complications in Takayasu's arteritis patients
by: I. E. Borodina, et al.
Published: (2021-12-01)

Successful Emergency Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in Takayasu’s Arteritis
by: Takanori Kawamoto, MD, PhD, et al.
Published: (2025-07-01)

Takayasu Arteritis: A current perspective on diagnosis and emerging treatments
by: Nicole Nitschke, et al.
Published: (2025-07-01)

OUTCOMES AND EFFECTIVENESS OF PERCUTANEOUS INTERVENTION IN PATIENTS WITH TAKAYASU’S ARTERITIS
by: Mustafa Yildiz, et al.
Published: (2014-01-01)

Difficulties in the Diagnosis and Management of Patients with Takayasu’s Arteritis: A Description of a 5-Year Clinical Follow-Up
by: A. V. Petrov, et al.
Published: (2023-10-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
by: P. I. Novikov, et al.
Published: (2018-07-01)

INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE
by: T. V. Beketova, et al.
Published: (2017-10-01)

Predictors of cardiovascular complications in patients with Takayasu’s arteritis: results of a retrospective study and analysis of autopsy materials
by: I. E. Borodina, et al.
Published: (2019-11-01)

Arteritic Anterior Ischemic Optic Neuropathy in Takayasu Arteritis: An Ominous Systemic Sign?
by: Kaviyapriya Natarajan, et al.
Published: (2025-07-01)

International guidelines for the management of giant cell arteritis and polymyalgia rheumatica: The 2015 results
by: T. V. Beketova, et al.
Published: (2016-10-01)

The efficacy of interleukin-6 inhibitor tocilizumab for takayasu’s arteritis, after insufficient response to previous treatment with glucocorticoids, methotrexate, cyclophosphamide, fludarabine. (A case report)
by: V. N. Antipova, et al.
Published: (2021-01-01)

Case Report: Can early full-course tocilizumab therapy reverse vascular stenosis in Takayasu arteritis?
by: Congqi Hu, et al.
Published: (2025-06-01)

Effectiveness and safety of TNF-α inhibitors and il-6 pathway antagonists for refractory Takayasu arteritis
by: V. E. Logina, et al.
Published: (2024-12-01)

Takayasu's arteritis in a patient with suspected acute coronary syndrome — a literature review and a case report
by: D. A. Grabovyi, et al.
Published: (2021-04-01)

A Case Report of Differential Diagnosis of Causes of Severe Valvular Heart Disease (Takayasu's Arteritis, Infective Endocarditis and Myxomatous Degeneration) with the Key Role of Histological and PCR Examination
by: A. S. Pisaryuk, et al.
Published: (2023-01-01)

The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review
by: Liala Moschetti, et al.
Published: (2025-07-01)

Giant Cell Arteritis
by: E. V. Shevchenko, et al.
Published: (2025-01-01)

Current imaging techniques in large vessel vasculitis
by: T. V. Beketova, et al.
Published: (2022-03-01)

Nonspecific aortoarteritis as a Cause of Aortic Dissection in a Middle Aged Man
by: O. V. Tsygankova, et al.
Published: (2022-05-01)

Review of guideline for the management of large vessel vasculitis presented in 2021 by the American College of Rheumatology / Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2022-05-01)

Takayasu’s arteritis with involvement of small cutaneous vessels - with regard to a clinical case
by: Ma. Cristina Fialho, et al.
Published: (2025-04-01)

New imaging strategy for large vessel vasculitis (based on the EULAR-2023 recommendations)
by: O. N. Egorova, et al.
Published: (2023-12-01)

Vision Loss in the Elderly: Focus on Giant Cell Arteritis (Clinical Observation)
by: A. V. Novikova, et al.
Published: (2024-04-01)

The role of interleukin 17 in the pathogenesis of giant cell arteritis: new possibilities for pharmacotherapy
by: E. L. Nasonov, et al.
Published: (2024-12-01)

Giant Cell Arteritis in Ophthalmology Practice: a Case Report
by: V. A. Chernukha, et al.
Published: (2019-03-01)

EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY
by: T. V. Beketova, et al.
Published: (2018-05-01)

THE CASE OF THE GIANT-CELL ARTERITIS MANIFESTED AS DORSOLATERAL MEDULLARY INFARCTION
by: V. S. Akimov, et al.
Published: (2014-10-01)

Clinical manifestations and prognosis of giant cell arteritis: A retrospective cohort study
by: E. E. Filatova, et al.
Published: (2024-01-01)

Occipital Strokes and Bilateral Oculomotor Palsy Due to Bilateral Giant Cell Arteritis
by: Mohammed Abu-Rumaileh, et al.
Published: (2025-06-01)

Aortic Aneurysms in Takayasu Arteritis
by: Regina, Guido, et al.
Published: (2011)

Giant cell arteritis. Part II. Treatment
by: Azamat Makhmudovich Satybaldyev
Published: (2012-12-01)

Giant cell arteritis. Part I. Terminology, classification, clinical manifestations, diagnosis
by: Azamat Makhmudovich Satybaldyev
Published: (2012-09-01)

Mycobacterium genavense-induced spindle cell pseudotumor presenting with symptoms of giant cell arteritis
by: Britney Le, BS, et al.
Published: (2025-09-01)

Damage to extracranial arteries in giant cell arteritis according to PET/CT
by: E. E. Filatova, et al.
Published: (2023-03-01)

Neuro-ophthalmic Manifestations of Giant Cell Arteritis: A Review
by: Jo-Ann Khoury, et al.
Published: (2025-06-01)